NCT03789032View on ClinicalTrials.gov

Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 3, 2018

Primary Completion Date

November 9, 2018

Study Completion Date

November 19, 2018

Conditions
Drug Interaction PotentiationPharmacokinetics
Interventions
DRUG

Vadadustat

Vadadustat 300 mg

DRUG

Rabeprazole

Oral Rabeprazole

Trial Locations (1)

G1P 0A2

inVentiv Health Clinique Inc., Québec

Sponsors
All Listed Sponsors
lead

Akebia Therapeutics

INDUSTRY

NCT03789032 - Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat | Biotech Hunter | Biotech Hunter